Physician profile
Alexander A Erbella
NPI 1154882140
$922.23
in general payments reported to CMS, 2019-2025
10 companies · $843 in 2025
The $843 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $79.13 · 2025: $843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $922.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $455.78 | 2025 | |
| Surgenex LLC | $134.93 | 2025 | Renograft, Pellograft, Surmatrix |
| Stability Biologics, LLC | $54.77 | 2025 | |
| Innovation Technologies INC | $50.28 | 2024 | Irrisept |
| Neuros Medical, INC. | $48.93 | 2025 | Altius |
| Biocomposites INC | $46.97 | 2025 | Stimulan |
| Medtronic, INC. | $43.52 | 2025 | Signia, Transorb |
| Ethicon US, LLC | $38.94 | 2025 | Stratafix, Echelon Flex, Vistaseal |
| Smith+Nephew, INC. | $33.19 | 2024-2025 | Pico, Renasys Touch, Grafix Pl |
| Merck Sharp & Dohme LLC | $14.92 | 2024 | Lynparza, Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Erbella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.